مواقع التدريسيينجامعة الكوفة
حيدر جاسب عصاد اللامي
أستاذ مساعد

حيدر جاسب عصاد اللامي

English Version
0بحث منشور
0محاضرة
0اهتمام بحثي

الملف الشخصي

الاستاذ المساعد الدكتور
حيدر جاسب عصاد اللامي

 شهادة الدكتوراه في الادويه السريرة والعلاجيات من كلية الطب جامعة النهرين
 شهادة الماجستير في الادوية و العلاجيات من كلية الطب جامعة الكوفة
 شهادة بكلوريوس في علوم الصيدلة كلية الصيدلة جامعة بغداد

المواد العلمية التي يدرسها
1. العلاجيات
2. الصيدله السريريه و تطبيقات الصيدلة
3. صيدلة المجتمع
4. تدريب مستشفيات
5. اقتصاد دوائي
6. حركيات الدواء السريرية
7. تطبيقات علاجية متقدمة
الاهتمامات البحثية
1. التطبيق السريري للادوية في مرض السكر و الأمراض الأيضية الاخرى
2. التطبيق السريري للادوية في تصلب الشرايين و امراض القلب
3. تطبيقات الصيدلة و الاستعمال الامثل والصحيح للادويه

الاهتمامات البحثية

2

البحوث المنشورة

9
2021

Evaluation of the convalescent plasma therapy effectiveness and the factors that influence the therapeutic outcome in hospitalized COVID-19 patients: A retrospective cohort study.

الباحثونZainab Ibadi, ، Hayder Assad, Hayder Fawzi
المجلةF1000Research
مختصر البحث

As an effective antiviral therapy is not available for the treatment of the current rapidly and continuously spreading coronavirus disease (COVID-19), it is very crucial to find an alternative treatment strategy. Convalescent plasma (CP) therapy has been used for prevention and treatment of many emerging infectious diseases, however, the results of current studies on CP in COVID-19 are not consistent. Therefore, this study aimed to evaluate the effectiveness of CP therapy in hospitalized patients with COVID-19, while evaluating patient and donor-related factors that might influence the therapeutic outcome. Methods: We conducted a retrospective cohort study on 312 patients with either severe or critical COVID-19, who were admitted to Al-Hakeem and Al-Amal hospitals in Al-Najaf city, Iraq from June to August 2020. The patients were allocated to either the plasma therapy group (152 patients) who received CP combined with standard therapy or the standard therapy group (160 patients). The outcome measures were the 21-day mortality rate and time to clinical improvement. Results: The overall cumulative survival rate was significantly higher in patients who received CP compared to standard therapy alone at 21 days (68.3% vs. 46.8%, p-value = 0.010), with mean survival at 17.6 vs. 15.3 days, (p-value = 0.010). In multivariate analysis, the plasma therapy effect was an independent predictor of survival (adjusted hazard ratio, 95% confidence interval: 0.368, 0.177 – 0.765). In terms of clinical improvement, the use of CP resulted in shorter clinical improvement (median duration of improvement: 8 vs. 11 days, p-value = 0.007), with 74.3 …

2020

Pharmacist role to enhance the prescribing of hospital discharge medications for patients after heart attack

الباحثونAmina M Jabri، Hayder Ch Assad, Ali Azeez Al-Jumaili
المجلةSaudi Pharmaceutical Journal
مختصر البحث

Abstract Objectives This study aimed to explore the cardiologist adherence with ACC/AHA guidelines on discharge medications for patients admitted with acute coronary syndrome (ACS), assess the predictors of cardiologist non-adherence and measure the impact of pharmacist intervention on improving guideline adherence. Methods The study included two consecutive phases: observation and intervention. It was carried out at Al-Najaf Center for Cardiac Surgery and Catheterization, Iraq, from August through December 2018. In the observation phase, medical records were reviewed retrospectively in order to assess the adherence to guideline. The intervention phase was performed prospectively by the clinical pharmacist, who conducted interventions including auditing, feedback and discussion with every prescriber. The reference of the recommendations was the guideline of American Heart Association/American College of Cardiology guideline (AHA/ACC). The primary outcome was the proportion of patients discharged with optimal treatment. Independent T-test was used to measure the difference in the means of age between the two patient groups. For categorical variables (gender, diagnosis, and comorbidities), chi-square test was used. Binary logistic regression was used to identify patient and disease characteristics associated with receiving optimal discharge regimen. Results The observation phase included 100 patients with ACS, while the intervention phase included 105 patients. A total of 50 interventions were performed by pharmacist, of which adding necessary medication was the most frequent (88%), followed by dose optimization (10%), and removing medication duplication (2%). Seventy-four percent of the provided recommendations were accepted by the cardiologists. Pharmacist intervention caused significant (P-value < 0.05) improvement (increasing) in the prescribing of β-blockers, ACE inhibitors/ARBs, statins, and the proportion of patients who received all optimal five therapies (from 35% in observation phase to 80% after intervention). Conclusion This study showed that pharmacist intervention had a considerable positive impact on the cardiologist prescribing pattern of the essential discharge medications for patients with ACS which could improve patient clinical outcomes.

2020

Evaluation of The Prescribing Practice of Postoperative Fluid Therapy in Comparison with The Guideline Recommendations

الباحثونHayder Ch. Assad ، Sarah K. Abbood
المجلةUniversity of Thi-Qar Journal Of Medicine
مختصر البحث

The post-operative fluid therapies are considered a key part of surgical care and have attracted more attention and importance over the last period because of their remarkable impact on post-surgical outcomes. Several studies showed inappropriate and suboptimal therapy of intravenous fluid and associated with many compactions such as Weight gain due to fluid overload and electrolyte abnormalities. Therefore in 2013, a new guideline had been initiated by the National Institute of Health and Care Excellence dealing with fluid therapy in adults. This study aims to assess the current practice of fluid therapy versus the guideline. Methods: The study was a prospective observational with 105 patients match the eligibility criteria and only 84 are included. The patient’s body weight, amount of fluid given to patients were calculated and compared to guideline also, serum sodium and serum potassium measured before and after fluid therapy. Results: The main results of this observational study demonstrated that the amount of fluid is significantly higher than the recommended amount by a guideline and lack of correlation with the body weight. Also, the body weight increased and serum potassium decreased significantly after two days of fluid therapy. Increased incidence of electrolytes abnormalities and trend of use of more saline containing fluids with less ringer was also observed. Conclusions: The data of current practice collectively indicated that extra amounts of fluid were prescribed resulted in increasing body weight of patients and appearance of electrolytes disturbances.

202

Pharmacotherapy prescribing pattern and outcome for hospitalized patients with severe and critical COVID-19

الباحثونHayder Assad
المجلة Uniwersytet Medyczny w Lublinie
مختصر البحث

The majority of the patients recovered and were discharged alive (66%), however, the inhospital mortality rate was 26%. Interestingly, patients treated with enoxaparin alone or in combination with hydroxychloroquine were associated with better outcome. The prescribing pattern of COVID-19 specific medications and supportive care is aligned with guideline recommendations and associated with a beneficial therapeutic outcome.

2019

Melatonin Improves Erythropoietin Hyporesponsiveness via Suppression of Inflammation

الباحثونEvan Noori Hameed، Haydar F Hadi Al Tukmagi 2, Hayder Ch Assad Allami 1
المجلةBentham science
مختصر البحث

Abstract Background: Inadequate response to Erythropoietin Stimulating Agents (ESA) despite using relatively larger doses regimen represents a potential risk factor of Cardiovascular (CV) related mortality in addition to health-care economic problems in anemic patients with Chronic Kidney Disease (CKD). Erythropoietin (EPO) hyporesponsiveness related to inflammation has been increased progressively. Melatonin is well known as a potent anti-inflammatory agent. Therefore, the current study was designed to evaluate whether melatonin could improve anemic patients response to EPO. Methods: This single controlled clinical study was carried out in 41 CKD patients with hemoglobin (Hb) levels less than 11g/dl divided randomly in a 1:1 ratio into 2 groups; treatment group who received 5mg melatonin plus their regular treatments and control group who received their regular treatments only. Hematological and iron status parameters include Hb level, serum iron (S. iron), Transferrin Saturation Ratio (TSAT) and serum ferritin (S. ferritin) in addition to inflammatory parameters that include tissue necrotic factor alfa (TNF-α), interleukin-1beta (IL-1β) and interleukin-6 (IL-6) determined before and after 12 weeks of treatment. Results: Melatonin remarkably increases the Hb level with a significant increase in S. iron and TSAT compared to baseline. The elevation of S. iron and TSAT was significantly higher in the melatonin group. Additionally, all inflammatory markers estimated were reduced significantly by melatonin compared to base line and control group. Conclusion: The results of the current study showed that melatonin has an advantageous effect on improving EPO response in anemic patients with CKD.

2019

Pharmacist intervention to enhance postoperative fluid prescribing practice in an Iraqi hospital through implementation of NICE guideline

الباحثونSarah K Abbood, ، Hayder C Assad, Ali A Al-Jumaili
المجلةPharmacy Practice (Granada)
مختصر البحث

Abstract Objective: The objectives of this study were to evaluate the current practice of postoperative fluid prescribing and assess the effectiveness of pharmacist-led intervention in the implementation of the National Institute of Health and Care Excellence (NICE) fluid therapy guideline in an Iraqi hospital. Methods: The prospective interventional study was conducted at AL-Hilla Teaching Hospital, Babylon, Iraq between November 2017 and July 2018. The study included two phases: The pre-intervention phase with 84 patients and the post-intervention phase with 112 patients. A pharmacist provided training and educational sessions for the hospital physicians and pharmacists about the NICE guideline of fluid therapy. The researcher calculated the amount of given post-operative fluids and compared to the NICE guideline and also measured the patients' body weight, serum Na, K and creatinine pre-and post-operatively. Results: The pre-intervention phase showed no correlation between the amounts of prescribed fluids and body weight which caused increases in patients' body weight. In pre-intervention phase, 6% of patients experienced hyponatremia, 19% had hypernatremia and 7.1% had hypokalemia. In the post-intervention phase, abnormal level of electrolytes and patient weight gain decreased significantly. Additionally, the intervention led to a strong correlation between body weight and amount of prescribed fluids in addition to lowering the incidence of electrolyte disturbances. Conclusions: A high proportion of patients in the pre-intervention phase experienced fluid overload, weight gain and electrolyte disturbances when fluid therapy was not prescribed in accordance with the NICE guidelines. The pharmacist-led intervention increased the surgeon awareness of the proper use of the NICE guideline which decreased the incidence of fluid-related complications and the inconsistency of fluid prescribing. Pharmacists can play a critical role to enhance post-operative fluid prescribing and minimize fluid-induced complications.

2019

Evaluation of Prescribing Practice at Secondary Care Units in Annajaf Governorate, Iraq.

الباحثونAli Mohammed Abd Alridha, h، Hayder Chassib Assad, Karrar Mohammed Hasan Al-Gburi, Abulfadhel Jaber Neamah Al-Shaibani, Karrar Talib Khudair Albo Hamra
المجلةndian Journal of Forensic Medicine & Toxicology
مختصر البحث

Rational drug prescribing has been proven fundamental to upgrade the quality of healthcare services. Examining the existing practice is essential to develop a better understanding of the successful encounters and to identify the areas of challenges where a counter plan can be directed. The aim of this work is to evaluate the prescribing practice in Annajaf Governorate, Iraq. A descriptive cross-sectional study was conducted in three government hospitals. 404 discharge prescriptions (23medications) were collected and analyzed according to the WHO model of rational prescribing. Index of rational medicine prescribing (IRMP) was used as an overall indicator of rational prescribing. The main finding was that the percentage values (%±standard deviation) of prescribing indicators were substandard for antibiotic prescribing (83.91%±0.37 vs.≤ 30%), generic prescribing (37.82%±2.17 vs. 100%), injection prescribing …

2018

Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis

الباحثونReem Ali Shaker، Samer Hassan Abboud, Hayder Chasib Assad & Najah Hadi
المجلةBioMed central
مختصر البحث

Doxorubicin (DOX) is commonly used in the treatment of many types of cancers but its cardiotoxicity is limiting its clinical use. Beyond its anticoagulant action, enoxaparin (ENX), a low molecular weight heparin, has been shown to exert multiple pharmacological actions including antioxidant, anti-inflammatory and antiapoptotic effects. Therefore, the current study aimed to assess if ENX could ameliorate cardiotoxicity induced by DOX. Twenty-one adult male Wistar albino rats were randomly allocated into three groups (n = 7 each) of control, receiving 0.9% saline (i.p.), DOX, receiving 2.5 mg/kg of DOX (i.p.) thrice weekly; and DOX + ENX, receiving ENX (250 IU/kg/day i.p.) and a DOX dose equivalent to that of the DOX only group. DOX-induced cardiotoxicity was indicated by marked increases in cardiac troponin I (cTnI) and severe histological lesions, which significantly correlated with cardiotoxicity, oxidative stress, inflammation and apoptosis markers, compared to controls. DOX group also showed elevations in malondialdehyde (MDA), a marker of oxidative stress, and reductions in total antioxidant capacity (TAC). Cardiac inflammatory markers including tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β) and caspase-3, an apoptotic marker, were also elevated in the DOX group. DOX, however, did not significantly alter brain natriuretic peptide (BNP) levels. ENX significantly attenuated, but not completely reversed, DOX-induced cardiotoxicity through lowering cTnI and improving cardiomyopathy histopathological scores as compared to the DOX group. ENX also decreased MDA, increased TAC of rats’ heart to levels relatively

2014

Effect of Cabergoline on Body Weight, Glycemic Control and Insulin Resistance in Patient with Obesity and Prediabetes

الباحثونHayder Ch. Assad1 ، 1 , Hamoudi A. Mosah2 , Hashim M. Hashim3
المجلةInt. J. Pharm. Sci. Rev. Res., 29(2), November – December 2014; Article No. 36, Pages: 210-215
مختصر البحث

Dopaminergic hypofunction have been involved in the pathogenesis of obesity and impaired glucose homeostasis. The aim of this study is to determine the effect of cabergoline on body weight, glycemic control and insulin resistance in pre-diabetic obese patients. This 12 week prospective control clinical study randomized 44 obese pre-diabetic patients into three groups. Group 1(N=13) the control, group 2 (N=16) received metformin 500mg-850mg BID and group 3 (N=15) received cabergoline 0.25-0.5mg twice weekly. The weight loss was not different among the three groups. Significant glycemic improvement started after 8 week of cabergoline while after 4 week of metformin treatment. At the end of study, cabergoline improved glycemic control and insulin resistance greater than control group. Metformin improved glycemic control greater than cabergoline while the change in insulin resistance was not significant between metformin and cabergoline. We can conclude that cabergoline improve glycemic control and insulin resistance in obese pre-diabetic patient

المحاضرات

4
عرض التفاصيل